WHO tips have to have manufacturers to employ a constant threat management procedure for sterility test isolators, which include regular possibility assessments and the event of chance-centered control methods. Manufacturers planning to implement these techniques will have to provide sturdy validation information to display their equivalence to pharmacopoeial strategies. waiting for link from Forum Profiles (6)